Science 37 Reports First Quarter 2022 Financial Results
RESEARCH TRIANGLE PARK, N.C., May 09, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
RESEARCH TRIANGLE PARK, N.C., May 09, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
Roermond, Netherlands–(Newsfile Corp. – May 9, 2022) – Reflex Finance, a hyper-deflationary token running on…
New Delhi, India, May 9, 2022 – (ACN Newswire) – India played host to one…
BOSTON–(BUSINESS WIRE)–Gelesis (NYSE: GLS), the maker of Plenity® for weight management, today announced that the…
PALO ALTO, Calif. & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) today announced that Ali Parsa, Founder and…
PALO ALTO, Calif.–(BUSINESS WIRE)–Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct its…
Company heads to ACT Expo with 6th generation platform featuring new Motiv co-designed Nidec motor…
Strategic distribution agreement leverages a leading IT security solutions distributor’s expertise to cover the Indian…
DUBLIN–(BUSINESS WIRE)–The “United States Cold Chain Logistics Market – Growth, Trends, COVID-19 Impact, and Forecasts…
ORION CORPORATION PRESS RELEASE 9 May 2022 at 10.00 EEST The negotiations under the Act…
Oslo (Norway), 9 May 2022 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing…
Trial did not demonstrate efficacy on the key clinical endpoints Oxurion to focus on its…
Abstract supports ongoing Phase 3 program and planned NDA submission LONDON and RALEIGH, N.C., May…
SAN MATEO, Calif. & MADRID–(BUSINESS WIRE)–$GWRE #Bdeo—Guidewire (NYSE: GWRE) and Bdeo Technologies S.L. (Bdeo) announced…
DALLAS–(BUSINESS WIRE)–Kosmos Energy Ltd. (“Kosmos” or the “Company”) (NYSE/LSE: KOS) announced today its financial and…
TOKYO, May 9, 2022 – (JCN Newswire) – TOYOTA GAZOO Racing earned its first win…
Advanced Automation Aims to Optimize Service Lab Efficiency and Highly Reproducible Data Production from HiFi…
New York, New York–(Newsfile Corp. – May 7, 2022) – The HotMoon team is pleased…
Los Altos Hills, California, May 07, 2022 (GLOBE NEWSWIRE) — Kyto Technology & Life Science,…
— Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine…